Figure 3From: Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysisKaplan-Meier estimates of the survival of elderly locoregionally advanced nasopharyngeal carcinoma patients with severe comorbidities (ACE-27 score of 2–3), by treatment group (CRT vs. RT). (A) overall survival and (B) cancer-specific survival.Back to article page